• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection

tetano

Editor, Senior Moderator
Viruses. 2019 Sep 10;11(9). pii: E840. doi: 10.3390/v11090840.
[h=1]Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection.[/h] Kim CW[SUP]1[/SUP], Yoo HJ[SUP]2[/SUP], Park JH[SUP]3[/SUP], Oh JE[SUP]4[/SUP], Lee HK[SUP]5,[/SUP][SUP]6,[/SUP][SUP]7[/SUP].
[h=3]Author information[/h] 1 Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea. chaewon.kim@kaist.ac.kr. 2 Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea. yoohyejee@kaist.ac.kr. 3 Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea. janghyun.park@kaist.ac.kr. 4 Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea. Jieun.oh@kaist.ac.kr. 5 Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea. heungkyu.lee@kaist.ac.kr. 6 Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea. heungkyu.lee@kaist.ac.kr. 7 KAIST Institute for Health Science and Technology, KAIST, Daejeon 34141, Korea. heungkyu.lee@kaist.ac.kr.

[h=3]Abstract[/h] Influenza is an infectious respiratory illness caused by the influenza virus. Though vaccines against influenza exist, they have limited efficacy. To additionally develop effective treatments, there is a need to study the mechanisms of host defenses from influenza viral infections. To date, the mechanism by which interleukin (IL)-33 modulates the antiviral immune response post-influenza infection is unclear. In this study, we demonstrate that exogenous IL-33 enhanced antiviral protection against influenza virus infection. Exogenous IL-33 induced the recruitment of dendritic cells, increased the secretion of pro-inflammatory cytokine IL-12, and promoted cytotoxic T-cell responses in the local microenvironment. Thus, our findings suggest a role of exogenous IL-33 in the antiviral immune response against influenza infection.


[h=4]KEYWORDS:[/h] IL-33; antiviral immunity; influenza virus

PMID: 31509992 DOI: 10.3390/v11090840
Free full text
 
Back
Top Bottom